Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’

标题

Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’

作者

关键词

Gastrointestinal stromal tumour, GIST, Resistance, Imatinib, Sunitinib, Cabozantinib, KIT, MET, AXL, VEGFR

出版物

EUROPEAN JOURNAL OF CANCER

Volume 134, Issue -, Pages 62-74

出版商

Elsevier BV

发表日期

2020-05-26

DOI

10.1016/j.ejca.2020.04.021